111 related articles for article (PubMed ID: 10075006)
1. Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients.
Wikström P; Westin P; Stattin P; Damber JE; Bergh A
Prostate; 1999 Mar; 38(4):268-77. PubMed ID: 10075006
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
3. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
Wong YC; Xie W; Tsao SW
Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 and prostate cancer.
Wikström P; Bergh A; Damber JE
Scand J Urol Nephrol; 2000 Apr; 34(2):85-94. PubMed ID: 10903068
[TBL] [Abstract][Full Text] [Related]
5. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
7. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.
Wikström P; Stattin P; Franck-Lissbrant I; Damber JE; Bergh A
Prostate; 1998 Sep; 37(1):19-29. PubMed ID: 9721065
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
10. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
12. Role of transforming growth factor-beta1 in prostate cancer.
Wikström P; Damber J; Bergh A
Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
14. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
Adler HL; McCurdy MA; Kattan MW; Timme TL; Scardino PT; Thompson TC
J Urol; 1999 Jan; 161(1):182-7. PubMed ID: 10037394
[TBL] [Abstract][Full Text] [Related]
17. The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.
Ohlson N; Bergh A; Nygren K; Stattin P; Wikström P
Eur Urol; 2006 Apr; 49(4):675-83. PubMed ID: 16387414
[TBL] [Abstract][Full Text] [Related]
18. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
19. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
Gold LI; Sung JJ; Siebert JW; Longaker MT
Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of transforming growth factor-beta receptors in a rabbit zone II flexor tendon wound healing model.
Ngo M; Pham H; Longaker MT; Chang J
Plast Reconstr Surg; 2001 Oct; 108(5):1260-7. PubMed ID: 11604629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
